Mr. Ashish Malik reports

BEE VECTORING TECHNOLOGIES ANNOUNCES PARTNERSHIP STRATEGY UPDATE

Bee Vectoring Technologies International Inc. has provided an update on the company's strategic partnership strategy with several multinational agriculture companies.

Partnership development is Bee Vectoring's core strategy for quickly scaling business and substantially broadening its addressable market. Allocating resources to tap into large, established channels is the most cost-efficient way to access more buyers, enter more distribution and marketing channels, and utilize sales teams that are experienced and deeply embedded in key regions and key crops around the world.

"BVT is deliberately and aggressively moving forward with strategic partnership initiatives, and we are currently in a good position to do this with several global partners," said Ashish Malik, chief executive officer of BVT. "Recent trial announcements in Spain with Agrobio, Mexico, with a major multinational grower, South Africa with MBFi, and expanding application of our proprietary plant-beneficial microbe, Clonostachys rosea CR-7, as a foliar application with our first sale to BioSafe, shows this is exactly what our multinational partners are looking for: large addressable markets with significant crop breadth, wide geography and an array of application methods. By creating value for them, we are cementing long-term relationships with immeasurable value for BVT's future."

The company is also pursuing partnerships in the large soybean seed treatment market, where one of the multinationals has conducted multiyear trials with BVT's CR-7. In the company's own trials in the United States, CR-7-treated soybean crops have consistently showed increased crop yields that outperformed the base seed treatment, producing larger, healthier plants.

• Wherever CR-7 was applied, the results outperformed the base seed treatment 81 per cent of the time.
• On average, a three-bushel yield per acre increase was reported with CR-7 added, which is about 4 per cent higher than the base seed treatment.
• Multiyear trials have shown CR-7 to be an effective treatment against sudden death syndrome (SDS), a huge challenge for soybean growers.

"Our multiyear work has included trials around the globe, and we have ongoing collaborations with key agriculture industry players in a number of product development and crop areas," said Mr. Malik. "These initiatives have shown very promising results and market opportunities -- successes that have intrigued these multinational businesses and encourage them to further pursue partnership with BVT."

About Bee Vectoring Technologies International Inc.

Bee Vectoring, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240-billion crop protection and fertilizer market. Bee Vectoring has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees. Bee Vectoring's award-winning technology, precision vectoring, is completely harmless to bees and allows minute amounts of naturally derived pesticides (called biologicals) to be delivered directly to blooms, providing improved crop protection and yield results than traditional chemical pesticides -- and improving the health of the soil, the microbiome and the environment. Currently, Bee Vectoring has over 55 granted patents, many more patents pending in all major agricultural countries worldwide and has U.S. Environmental Protection Agency registration of its Vectorite with CR-7 (EPA registration No. 90641-2) for sale as a registered biological fungicide for use on the labelled crops.

We seek Safe Harbor.